IL10 and type 2 diabetes mellitus: In patients with T2DM, the acute elevation of plasma IL-6 in circulation plays a protective role against systemic inflammation by promoting plasma levels of anti-inflammatory IL-10 and IL-1 receptor antagonist (27).